Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Amicus Therapeutics Inc FOLD

Healthcare Biotechnology
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FOLD)

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report

GlobeNewswire March 20, 2024

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024

GlobeNewswire March 1, 2024

Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates

GlobeNewswire February 28, 2024

Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

GlobeNewswire February 15, 2024

Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) at the 20th Annual WORLDSymposium(TM)

GlobeNewswire February 8, 2024

Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium(TM) 2024

GlobeNewswire February 1, 2024

Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook

GlobeNewswire January 7, 2024

Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2024

Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO

GlobeNewswire December 5, 2023
View More News ››

Opinion & Analysis (NDAQ:FOLD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FOLD)

7 THINGS TO KNOW ABOUT AMICUS THERAPEUTICS

$FOLD   Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment...
AviseAnalytics - March 2, 2022

RE:$FOLD upgraded $CTRV $AVXL $TBPH & $ASTI

Hi, what do you mean by FOLD upgraded? its going down! any input why it is?
TrailBlazer666 - October 6, 2017

$FOLD upgraded $CTRV $AVXL $TBPH & $ASTI

$FOLD upgraded $CTRV $AVXL $TBPH $ONCE & $ASTI I like my US biotechs today all have good news out. Putting them on watch as the...
osirus1 - October 5, 2015

RE:RE:FOLD had two signals consecutive days!

Fold can be a big winner if it get FDA ok in near future. I can see big farma to buyout,,,,, I can be wrong but you never know what...
mark26 - September 6, 2014

RE:FOLD had two signals consecutive days!

a lots if upside possible in near future,,,, looks like they have something in works... Mark
mark26 - August 30, 2014

FOLD had two signals consecutive days!

25% gain on this yesterday, decent breaout, it still could keep running but seems to pull back and close not so strong. http...
Pennystockformula - June 4, 2014
View more Bullboard ››

Goldflare Exploration Inc

Goldflare Exploration Inc

Goldflare Exploration Inc. is a Canada-based mineral exploration company. The Company specializes in gold exploration in the ...
View More »